What fruits cannot be eaten with lenvatinib and what are the contraindications?

Lenvatinib is a targeted anti-tumor drug, specifically lenvatinib mesylate capsules. It is a multi-kinase target inhibitor that mainly inhibits vascular endothelial growth factor receptor, fibroblast growth factor receptor and other kinases, thereby inhibiting the proliferation of tumor cells and the formation of tumor blood vessels, and plays an anti-tumor role. During the use of lenvatinib, special attention should be paid to the patient's dietary contraindications and potential drug interactions. Understanding this information is critical to ensuring the safety and effectiveness of treatment.

Although the official instructions for lenvatinib do not clearly list specific contraindicated fruits, patients should carefully choose fruits while taking the drug and avoid consuming types that may affect the effect of the drug or aggravate side effects. For example, certain citrus fruits (such as grapefruit) may interfere with the metabolism of drugs, causing higher drug concentrations in the body and increasing the risk of side effects. Therefore, patients are advised to consult a physician or nutritionist for personalized dietary advice while taking lenvatinib.

The use of lenvatinib is associated with a number of contraindications and potential drug interactions. This drug may cause serious heart problems, especially when used with other drugs to treat infections, asthma, heart disease, high blood pressure, etc. The risk may be further increased. Therefore, before starting treatment with lenvatinib, patients must inform their doctor in detail about all other medications they are taking, including prescription drugs, over-the-counter drugs, vitamins, and herbal products. In addition, lenvatinib may also cause allergic reactions, such as urticaria, difficulty breathing, etc., which require immediate medical treatment. Lenvatinib is contraindicated in female patients who are pregnant or may become pregnant because of the potential for serious harm to the fetus. Patients need to have a negative pregnancy test before starting treatment and use effective contraception while taking the drug and for at least30 days after stopping the drug.

In short, lenvatinib is a powerful cancer treatment drug, but its use must be strictly followed by your doctor's instructions. Patients should pay special attention to dietary taboos while taking the medication and avoid ingesting fruits that may affect the effect of the medication. Also, you must inform your doctor in detail about all other medications you are taking to prevent potential drug interactions and serious side effects. Lenvatinib is contraindicated in female patients who are pregnant or may become pregnant and should use effective contraceptive measures. In short, only standardized medication under the guidance of a doctor can ensure the safety and effectiveness of lenvatinib treatment.